Who has invested in dMed?

Vivo Capital, Legend Capital, Qiming Venture Partners, Lilly Asia Ventures are named among the investors backing dMed.

dMed Funding: $214M Raised, Series B (2019)

dMed funding overview

dMed is based in Shanghai, China. dMed has raised $214M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2019. The round record for dMed runs through 2019; nothing later has been disclosed. Investors on record include Vivo Capital, Legend Capital, Qiming Venture Partners, Lilly Asia Ventures. 4 distinct backers are named across the disclosed rounds.

dMed at a glance

Total raised: $214M
Latest round: Series B
Latest round date: October 2019
Headquarters: Shanghai, China
Notable investors: Vivo Capital, Legend Capital, Qiming Venture Partners, Lilly Asia Ventures

Frequently asked about dMed funding

How much has dMed raised?: dMed has raised $214M in total disclosed funding across the rounds on record.
Who has invested in dMed?: Vivo Capital, Legend Capital, Qiming Venture Partners, Lilly Asia Ventures are named among the investors backing dMed.
What was the latest dMed funding round?: The most recent disclosed round is a Series B, announced in October 2019.
Where is dMed based?: dMed is based in Shanghai, China.
When did dMed last raise?: The last disclosed dMed round closed in October 2019 at Series B.

Round data for dMed is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

dMed Funding: $214M Raised, Series B (2019)

dMed funding overview

dMed at a glance

Frequently asked about dMed funding

Companies related to dMed (36)

Browse related funding lists (9)